SCHEMBL14023142

SCHEMBL14023142

C=C(N)C1CCCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8059207 0.79
SCHEMBL12658636 0.79
SCHEMBL1405881 0.77
SCHEMBL440540 0.77
SCHEMBL1970431 0.77
SCHEMBL641808 0.77
SCHEMBL13627004 0.77
Hydrochloric Acid SCHEMBL3303102 0.76 KDM4E (0.96)
Hydrochloric Acid SCHEMBL2144598 0.76 KDM4E (0.96)
Hydrochloric Acid SCHEMBL4431863 0.76 KDM4E (0.96)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3833665-B1 DIAZABICYCLOOCTANONES AS INHIBITORS OF SERINE BETA-LACTAMASES ANTABIO SAS (FR) 2023-07-19 EP disclosed
EP-2931723-B1 NEW BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND -LACTAMASE INHIBITORS FEDORA PHARMACEUTICALS INC (CA) 2020-08-26 EP disclosed
EP-2857401-B1 NOVEL -LACTAMASE INHIBITOR AND METHOD FOR PRODUCING SAME MEIJI SEIKA PHARMA CO LTD (JP) 2019-09-18 EP disclosed
WO-2008140792-A1 DERIVATIVES OF FLUORENE, ANTHRACENE, XANTHENE, DIBENZOSUBERONE AND ACRIDINE AND USES THEREOF AVALON PHARMACEUTICALS (US) 2008-11-20 WO disclosed